PRDX2 and colonic neoplasm: Furthermore, a recent study showed that PRDX2 was related to resistance to 5-Fluorouracil (5-FU), one of the most common chemotherapeutic agents, and the reduced levels of PRDX2 could contribute to increasing the sensitivity of 5-FU in colon cancer cells [15].